ILC Therapeutics Ltd
ILC Therapeutics Ltd is a company focused on developing hybrid interferons, a class of engineered drugs with enhanced therapeutic profiles. The company is working on treatment options in various medical fields through its pipeline.
- Alfacyte™
- Dermacyte™
- Hybrid interferons
Locations
Digital Popularity
Social Media
Company Details
ILC Therapeutics Ltd is operated by ILC Therapeutics Ltd and is a Active company incorporated on 21 June 2012 with the registered office located in Glasgow, City of Glasgow. ILC Therapeutics Ltd was registered 13 years ago.
Status
Active
Size
Small
Directors
8
Age
13 years old
Employees
14
Turnover
Unreported
Total Assets
£3.18M
Cash in Bank
£1.95M
Total Liabilities
-£518.19K
Teams
6
4
2
1
Chief Executive Officer • Joined Apr 2020
Non Executive Director • Joined Mar 2022
Co Founder, Investor • Joined Sep 2014
Head Of Technical Operations • Joined Jan 2022
Chief Financial Officer • Joined May 2023
Financial Controller • Joined Nov 2022
Chief Executive Officer • Joined Apr 2020
Non Executive Director • Joined Mar 2022
Head Of Technical Operations • Joined Jan 2022
Chief Financial Officer • Joined May 2023
Chief Financial Officer • Joined May 2023
Financial Controller • Joined Nov 2022
Co Founder, Investor • Joined Sep 2014